FATE - Fate Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts11111111
Avg. Estimate-0.32-0.34-1.31-1.32
Low Estimate-0.39-0.39-1.47-1.68
High Estimate-0.18-0.19-0.86-0.47
Year Ago EPS-0.37-0.31-1.19-1.31
Revenue EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts99109
Avg. Estimate1.18M1.13M6.02M6.72M
Low EstimateN/AN/A2.63M1.14M
High Estimate1.95M1.75M8.1M20.3M
Year Ago Sales1.03MN/A4.74M6.02M
Sales Growth (year/est)14.90%N/A27.00%11.60%
Earnings History6/29/20189/29/201812/30/20183/30/2019
EPS Est.-0.32-0.25-0.24-0.24
EPS Actual-0.37-0.31-0.25-0.3
Difference-0.05-0.06-0.01-0.06
Surprise %-15.60%-24.00%-4.20%-25.00%
EPS TrendCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.32-0.34-1.31-1.32
7 Days Ago-0.32-0.34-1.31-1.32
30 Days Ago-0.32-0.33-1.3-1.28
60 Days Ago-0.3-0.32-1.23-1.19
90 Days Ago-0.26-0.28-1.07-1.05
EPS RevisionsCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesFATEIndustrySectorS&P 500
Current Qtr.13.50%N/AN/A0.01
Next Qtr.-9.70%N/AN/A0.03
Current Year-10.10%N/AN/A0.04
Next Year-0.80%N/AN/A0.10
Next 5 Years (per annum)N/AN/AN/A0.08
Past 5 Years (per annum)N/AN/AN/AN/A